Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic TargetsNicola Antonio di Meo, Giuseppe Lucarelli, Michele Battaglia et al.|International Journal of Molecular Sciences|2022Cited by 190
Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical PracticeFrancesco Lasorsa, Giuseppe Lucarelli, Nicola Antonio di Meo et al.|Biomedicines|2023Cited by 161
Association of NAFLD and Insulin Resistance with Non Metastatic Bladder Cancer Patients: A Cross-Sectional Retrospective StudyGiovanni Tarantino, Ciro Imbimbo, Felice Crocetto et al.|Journal of Clinical Medicine|2021Cited by 131
Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell CarcinomaFrancesco Lasorsa, Giuseppe Lucarelli, Monica Rutigliano et al.|Journal of Clinical Medicine|2023Cited by 129
The Role of Testosterone in the Elderly: What Do We Know?Biagio Barone, Felice Crocetto, Luigi Napolitano et al.|International Journal of Molecular Sciences|2022Cited by 116